Effectiveness and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases

Inflamm Bowel Dis. 2021 Oct 18;27(10):1698-1702. doi: 10.1093/ibd/izab112.
No abstract available

Keywords: biologics; combination therapy; inflammatory bowel disease; tofacitinib.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Products*
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Piperidines / adverse effects
  • Piperidines / chemistry
  • Piperidines / pharmacology
  • Pyrimidines / adverse effects
  • Pyrimidines / chemistry
  • Pyrimidines / pharmacology

Substances

  • Biological Products
  • Piperidines
  • Pyrimidines
  • tofacitinib